1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-13598A Valecobulin hydrochloride

Microtubule/Tubulin

Cancer

2020-01 Valecobulin hydrochloride
HY-15701B ADH-503

Complement System

Cancer

2020-01 ADH-503
HY-120877 MRT199665

Salt-inducible Kinase (SIK); AMPK; Apoptosis

Cancer

2020-01 MRT199665
HY-124759 CCR1 antagonist 9

CCR

Inflammation/Immunology

2020-01 CCR1 antagonist 9
HY-15701A (Z)-Leukadherin-1

Complement System

Cancer

2020-01 (Z)-Leukadherin-1
HY-117985B Evogliptin tartrate

Dipeptidyl Peptidase

Inflammation/Immunology;

Metabolic Disease

2020-01 Evogliptin tartrate
HY-17638 Mizagliflozin

SGLT

Metabolic Disease

2020-01 Mizagliflozin
HY-135406 (3R,5R)-Rosuvastatin Lactone

Others

Others

2020-01 (3R,5R)-Rosuvastatin Lactone
HY-50767S Palbociclib D8

CDK

Cancer

2020-01 Palbociclib D8
HY-135412 N-Methyl Duloxetine hydrochloride

Sodium Channel

Neurological Disease

2020-01 N-Methyl Duloxetine hydrochloride
HY-B0006C (R)-Carvedilol

Adrenergic Receptor

2020-01 (R)-Carvedilol
HY-A0095S Flibanserin D4

5-HT Receptor

Neurological Disease

2020-01 Flibanserin D4
HY-B0031S1 Quetiapine D4 hemifumarate

5-HT Receptor; Dopamine Receptor

Neurological Disease

2020-01 Quetiapine D4 hemifumarate
HY-135578 Artelinic acid

Parasite

Infection

2020-01 Artelinic acid
HY-17504C (3R,5R)-Rosuvastatin

HMG-CoA Reductase (HMGCR); Potassium Channel; Autophagy

Cardiovascular Disease;

Metabolic Disease

2020-01 (3R,5R)-Rosuvastatin
HY-133234 BMVC-8C3O

Others

Others

2020-01 BMVC-8C3O
HY-13662S Lansoprazole D4

Bacterial; Proton Pump

Cancer;

Inflammation/Immunology

2020-01 Lansoprazole D4
HY-113673 A-935142

Potassium Channel

Others

2020-01 A-935142
HY-135404 Anhydrosimvastatin

Others

Others

2020-01 Anhydrosimvastatin
HY-129388B LSD1-IN-7 benzenesulfonate

Histone Demethylase

Cancer

2020-01 LSD1-IN-7 benzenesulfonate